Structure

Physi-Chem Properties

Molecular Weight:  620.33
Volume:  646.399
LogP:  5.69
LogD:  3.913
LogS:  -5.42
# Rotatable Bonds:  8
TPSA:  105.2
# H-Bond Aceptor:  8
# H-Bond Donor:  0
# Rings:  6
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.21
Synthetic Accessibility Score:  5.1
Fsp3:  0.676
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.81
MDCK Permeability:  6.281078094616532e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.818
30% Bioavailability (F30%):  0.658

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.108
Plasma Protein Binding (PPB):  93.61839294433594%
Volume Distribution (VD):  1.469
Pgp-substrate:  8.485655784606934%

ADMET: Metabolism

CYP1A2-inhibitor:  0.036
CYP1A2-substrate:  0.043
CYP2C19-inhibitor:  0.123
CYP2C19-substrate:  0.113
CYP2C9-inhibitor:  0.395
CYP2C9-substrate:  0.05
CYP2D6-inhibitor:  0.04
CYP2D6-substrate:  0.049
CYP3A4-inhibitor:  0.582
CYP3A4-substrate:  0.442

ADMET: Excretion

Clearance (CL):  4.876
Half-life (T1/2):  0.235

ADMET: Toxicity

hERG Blockers:  0.118
Human Hepatotoxicity (H-HT):  0.179
Drug-inuced Liver Injury (DILI):  0.655
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.097
Maximum Recommended Daily Dose:  0.964
Skin Sensitization:  0.889
Carcinogencity:  0.102
Eye Corrosion:  0.006
Eye Irritation:  0.317
Respiratory Toxicity:  0.952

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475373

Natural Product ID:  NPC475373
Common Name*:   Melianin C
IUPAC Name:   [(1S,3R,5S,7R,8R,9R,10S,13S,17S)-1,7-diacetyloxy-4,4,8,10,13-pentamethyl-17-(5-oxooxolan-3-yl)-2,3,5,6,7,9,11,12,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] benzoate
Synonyms:   Melianin C
Standard InCHIKey:  UMDZHCRPOCMGPU-RCRHGASGSA-N
Standard InCHI:  InChI=1S/C37H48O8/c1-21(38)43-30-18-28-34(3,4)29(45-33(41)23-11-9-8-10-12-23)19-31(44-22(2)39)37(28,7)27-15-16-35(5)25(24-17-32(40)42-20-24)13-14-26(35)36(27,30)6/h8-12,14,24-25,27-31H,13,15-20H2,1-7H3/t24?,25-,27-,28-,29+,30+,31-,35-,36-,37+/m0/s1
SMILES:  O=C1OCC(C1)[C@@H]1CC=C2[C@@]1(C)CC[C@H]1[C@@]2(C)[C@H](OC(=O)C)C[C@@H]2[C@]1(C)[C@@H](OC(=O)C)C[C@H](C2(C)C)OC(=O)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL504483
PubChem CID:   44566527
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4571 Melia volkensii Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[10217705]
NPO4571 Melia volkensii Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[9461654]
NPO4571 Melia volkensii Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 = 21.85 ug ml-1 PMID[523070]
NPT83 Cell Line MCF7 Homo sapiens ED50 = 14.47 ug ml-1 PMID[523070]
NPT139 Cell Line HT-29 Homo sapiens ED50 = 18.05 ug ml-1 PMID[523070]
NPT376 Cell Line A498 Homo sapiens ED50 = 26.52 ug ml-1 PMID[523070]
NPT306 Cell Line PC-3 Homo sapiens ED50 = 4.73 10'-1 ug/ml PMID[523070]
NPT783 Cell Line MIA PaCa-2 Homo sapiens ED50 = 20.62 ug ml-1 PMID[523070]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475373 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.916 High Similarity NPC147561
0.9137 High Similarity NPC475552
0.9118 High Similarity NPC473081
0.9118 High Similarity NPC43241
0.9118 High Similarity NPC473758
0.9118 High Similarity NPC473109
0.9118 High Similarity NPC211137
0.9118 High Similarity NPC184747
0.9118 High Similarity NPC473085
0.9118 High Similarity NPC476094
0.9118 High Similarity NPC473060
0.9118 High Similarity NPC4341
0.9118 High Similarity NPC473112
0.9118 High Similarity NPC48017
0.9118 High Similarity NPC200592
0.9118 High Similarity NPC473613
0.9118 High Similarity NPC147880
0.9098 High Similarity NPC472656
0.9091 High Similarity NPC470278
0.9044 High Similarity NPC475652
0.9044 High Similarity NPC210591
0.9044 High Similarity NPC214550
0.9007 High Similarity NPC473403
0.9 High Similarity NPC473602
0.8971 High Similarity NPC283375
0.8971 High Similarity NPC183122
0.8963 High Similarity NPC291638
0.8963 High Similarity NPC66761
0.8963 High Similarity NPC195647
0.8963 High Similarity NPC472577
0.8963 High Similarity NPC17877
0.8921 High Similarity NPC177340
0.8921 High Similarity NPC147217
0.8921 High Similarity NPC246480
0.8921 High Similarity NPC139067
0.8921 High Similarity NPC270498
0.8921 High Similarity NPC191082
0.8921 High Similarity NPC475429
0.8921 High Similarity NPC473673
0.8889 High Similarity NPC474608
0.8889 High Similarity NPC48929
0.8857 High Similarity NPC470231
0.8857 High Similarity NPC57628
0.8857 High Similarity NPC51314
0.8857 High Similarity NPC188865
0.8857 High Similarity NPC95265
0.8857 High Similarity NPC163719
0.8857 High Similarity NPC472570
0.8857 High Similarity NPC11685
0.8857 High Similarity NPC95810
0.8857 High Similarity NPC70716
0.8857 High Similarity NPC67777
0.8857 High Similarity NPC472573
0.8857 High Similarity NPC125106
0.8857 High Similarity NPC472569
0.8857 High Similarity NPC25768
0.8857 High Similarity NPC476974
0.8841 High Similarity NPC183270
0.8841 High Similarity NPC477904
0.8824 High Similarity NPC473399
0.8824 High Similarity NPC473216
0.8794 High Similarity NPC472575
0.8794 High Similarity NPC469349
0.8794 High Similarity NPC473088
0.8794 High Similarity NPC171525
0.8794 High Similarity NPC470159
0.8794 High Similarity NPC471104
0.8794 High Similarity NPC472572
0.8794 High Similarity NPC200471
0.8794 High Similarity NPC158663
0.8794 High Similarity NPC29704
0.8794 High Similarity NPC472568
0.8794 High Similarity NPC184817
0.8794 High Similarity NPC174982
0.8794 High Similarity NPC472571
0.8794 High Similarity NPC470157
0.8794 High Similarity NPC96903
0.8794 High Similarity NPC476973
0.8794 High Similarity NPC177940
0.8794 High Similarity NPC70403
0.8786 High Similarity NPC163087
0.8777 High Similarity NPC16912
0.875 High Similarity NPC203486
0.8723 High Similarity NPC475759
0.8723 High Similarity NPC475122
0.8723 High Similarity NPC470152
0.8723 High Similarity NPC241951
0.8714 High Similarity NPC475135
0.8705 High Similarity NPC171207
0.8705 High Similarity NPC97667
0.8705 High Similarity NPC90614
0.8686 High Similarity NPC471864
0.8681 High Similarity NPC254558
0.8671 High Similarity NPC281717
0.8662 High Similarity NPC472556
0.8652 High Similarity NPC191387
0.8652 High Similarity NPC131966
0.8647 High Similarity NPC470753
0.8647 High Similarity NPC473220
0.8643 High Similarity NPC472576
0.8643 High Similarity NPC27377
0.8643 High Similarity NPC118080
0.8643 High Similarity NPC87448
0.8643 High Similarity NPC41481
0.8643 High Similarity NPC97947
0.8643 High Similarity NPC224491
0.8643 High Similarity NPC266374
0.8643 High Similarity NPC291599
0.8633 High Similarity NPC472371
0.8633 High Similarity NPC472395
0.863 High Similarity NPC472658
0.863 High Similarity NPC472657
0.8613 High Similarity NPC329913
0.8611 High Similarity NPC92293
0.8611 High Similarity NPC476975
0.8611 High Similarity NPC266265
0.8611 High Similarity NPC270590
0.8611 High Similarity NPC471101
0.8611 High Similarity NPC301556
0.8603 High Similarity NPC472394
0.8601 High Similarity NPC474935
0.8571 High Similarity NPC475400
0.8571 High Similarity NPC275592
0.8571 High Similarity NPC100913
0.8571 High Similarity NPC470765
0.8562 High Similarity NPC477905
0.8552 High Similarity NPC31829
0.8552 High Similarity NPC470245
0.8552 High Similarity NPC473214
0.8531 High Similarity NPC471107
0.8531 High Similarity NPC471100
0.8529 High Similarity NPC72915
0.8521 High Similarity NPC91703
0.8493 Intermediate Similarity NPC470153
0.8489 Intermediate Similarity NPC472545
0.8489 Intermediate Similarity NPC472551
0.8483 Intermediate Similarity NPC473215
0.8478 Intermediate Similarity NPC126516
0.8472 Intermediate Similarity NPC209592
0.8472 Intermediate Similarity NPC240115
0.8472 Intermediate Similarity NPC48599
0.8467 Intermediate Similarity NPC238370
0.8451 Intermediate Similarity NPC472546
0.8451 Intermediate Similarity NPC192658
0.8446 Intermediate Similarity NPC282239
0.8446 Intermediate Similarity NPC473611
0.844 Intermediate Similarity NPC87934
0.844 Intermediate Similarity NPC472547
0.844 Intermediate Similarity NPC162613
0.8435 Intermediate Similarity NPC472548
0.8429 Intermediate Similarity NPC39549
0.8429 Intermediate Similarity NPC262324
0.8425 Intermediate Similarity NPC7095
0.8425 Intermediate Similarity NPC112216
0.8414 Intermediate Similarity NPC473760
0.8392 Intermediate Similarity NPC477894
0.8392 Intermediate Similarity NPC95449
0.8389 Intermediate Similarity NPC217091
0.8389 Intermediate Similarity NPC106895
0.837 Intermediate Similarity NPC169913
0.8369 Intermediate Similarity NPC9905
0.8367 Intermediate Similarity NPC51602
0.8357 Intermediate Similarity NPC472374
0.8357 Intermediate Similarity NPC472372
0.8356 Intermediate Similarity NPC60509
0.8356 Intermediate Similarity NPC81698
0.8356 Intermediate Similarity NPC250046
0.8333 Intermediate Similarity NPC472393
0.8333 Intermediate Similarity NPC34943
0.8322 Intermediate Similarity NPC34012
0.8322 Intermediate Similarity NPC473632
0.8322 Intermediate Similarity NPC469730
0.8322 Intermediate Similarity NPC182869
0.8322 Intermediate Similarity NPC472549
0.8322 Intermediate Similarity NPC132599
0.8321 Intermediate Similarity NPC475508
0.831 Intermediate Similarity NPC79921
0.8309 Intermediate Similarity NPC195224
0.8299 Intermediate Similarity NPC161239
0.8299 Intermediate Similarity NPC165260
0.8299 Intermediate Similarity NPC198455
0.8298 Intermediate Similarity NPC327511
0.8298 Intermediate Similarity NPC205305
0.8298 Intermediate Similarity NPC243893
0.8296 Intermediate Similarity NPC275576
0.8296 Intermediate Similarity NPC473082
0.8289 Intermediate Similarity NPC476077
0.8286 Intermediate Similarity NPC477893
0.8278 Intermediate Similarity NPC471102
0.8276 Intermediate Similarity NPC125882
0.8276 Intermediate Similarity NPC127857
0.8267 Intermediate Similarity NPC323001
0.8267 Intermediate Similarity NPC326235
0.8255 Intermediate Similarity NPC237549
0.8255 Intermediate Similarity NPC265395
0.8255 Intermediate Similarity NPC77719
0.8255 Intermediate Similarity NPC249471
0.8255 Intermediate Similarity NPC473414
0.8255 Intermediate Similarity NPC256142
0.8255 Intermediate Similarity NPC472030

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475373 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8027 Intermediate Similarity NPD7236 Approved
0.7881 Intermediate Similarity NPD7239 Suspended
0.7769 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD7799 Discontinued
0.7676 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7664 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD7961 Discontinued
0.7552 Intermediate Similarity NPD7008 Discontinued
0.7465 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7445 Intermediate Similarity NPD7741 Discontinued
0.7421 Intermediate Similarity NPD7057 Phase 3
0.7421 Intermediate Similarity NPD7058 Phase 2
0.7403 Intermediate Similarity NPD6273 Approved
0.7388 Intermediate Similarity NPD6858 Approved
0.7388 Intermediate Similarity NPD7094 Approved
0.7348 Intermediate Similarity NPD2182 Approved
0.7346 Intermediate Similarity NPD8127 Discontinued
0.726 Intermediate Similarity NPD3764 Approved
0.7193 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD8166 Discontinued
0.7186 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD5951 Approved
0.7135 Intermediate Similarity NPD8407 Phase 2
0.7122 Intermediate Similarity NPD7610 Discontinued
0.7113 Intermediate Similarity NPD6287 Discontinued
0.7105 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD6663 Approved
0.7095 Intermediate Similarity NPD8032 Phase 2
0.7081 Intermediate Similarity NPD7819 Suspended
0.7081 Intermediate Similarity NPD5761 Phase 2
0.7081 Intermediate Similarity NPD5760 Phase 2
0.7078 Intermediate Similarity NPD7003 Approved
0.7059 Intermediate Similarity NPD8368 Discontinued
0.7052 Intermediate Similarity NPD8434 Phase 2
0.7045 Intermediate Similarity NPD164 Approved
0.7044 Intermediate Similarity NPD6591 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1238 Approved
0.6994 Remote Similarity NPD7768 Phase 2
0.698 Remote Similarity NPD7713 Phase 3
0.6974 Remote Similarity NPD3748 Approved
0.6972 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6971 Remote Similarity NPD8360 Approved
0.6971 Remote Similarity NPD8435 Approved
0.6971 Remote Similarity NPD8361 Approved
0.6968 Remote Similarity NPD4628 Phase 3
0.6963 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6954 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6939 Remote Similarity NPD5736 Approved
0.6937 Remote Similarity NPD7458 Discontinued
0.6909 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6906 Remote Similarity NPD2629 Approved
0.6899 Remote Similarity NPD7004 Clinical (unspecified phase)
0.689 Remote Similarity NPD4965 Approved
0.689 Remote Similarity NPD4967 Phase 2
0.689 Remote Similarity NPD4966 Approved
0.6859 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6857 Remote Similarity NPD4198 Discontinued
0.6833 Remote Similarity NPD8485 Approved
0.6832 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6829 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6821 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6818 Remote Similarity NPD5408 Approved
0.6818 Remote Similarity NPD5405 Approved
0.6818 Remote Similarity NPD5404 Approved
0.6818 Remote Similarity NPD5406 Approved
0.6813 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6812 Remote Similarity NPD1609 Clinical (unspecified phase)
0.681 Remote Similarity NPD37 Approved
0.6807 Remote Similarity NPD6234 Discontinued
0.6795 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6792 Remote Similarity NPD2534 Approved
0.6792 Remote Similarity NPD2532 Approved
0.6792 Remote Similarity NPD2533 Approved
0.6782 Remote Similarity NPD8313 Approved
0.6782 Remote Similarity NPD8312 Approved
0.6779 Remote Similarity NPD6832 Phase 2
0.6766 Remote Similarity NPD5494 Approved
0.6752 Remote Similarity NPD3750 Approved
0.6748 Remote Similarity NPD7411 Suspended
0.6735 Remote Similarity NPD1876 Approved
0.6728 Remote Similarity NPD3226 Approved
0.6725 Remote Similarity NPD7228 Approved
0.6721 Remote Similarity NPD8486 Clinical (unspecified phase)
0.671 Remote Similarity NPD2438 Suspended
0.671 Remote Similarity NPD2796 Approved
0.6706 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6706 Remote Similarity NPD7997 Clinical (unspecified phase)
0.6704 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6703 Remote Similarity NPD7497 Discontinued
0.6687 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6687 Remote Similarity NPD6599 Discontinued
0.6686 Remote Similarity NPD5844 Phase 1
0.6667 Remote Similarity NPD3025 Approved
0.6667 Remote Similarity NPD7055 Discontinued
0.6667 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6002 Phase 3
0.6667 Remote Similarity NPD2067 Discontinued
0.6667 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2346 Discontinued
0.6667 Remote Similarity NPD8150 Discontinued
0.6667 Remote Similarity NPD6764 Approved
0.6667 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7473 Discontinued
0.6667 Remote Similarity NPD3024 Approved
0.6667 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6005 Phase 3
0.6667 Remote Similarity NPD6004 Phase 3
0.6667 Remote Similarity NPD6765 Approved
0.6647 Remote Similarity NPD7075 Discontinued
0.6645 Remote Similarity NPD2799 Discontinued
0.6627 Remote Similarity NPD7199 Phase 2
0.6621 Remote Similarity NPD5125 Phase 3
0.6621 Remote Similarity NPD5126 Approved
0.6617 Remote Similarity NPD7798 Approved
0.6601 Remote Similarity NPD2979 Phase 3
0.6601 Remote Similarity NPD4140 Approved
0.6599 Remote Similarity NPD3972 Approved
0.6597 Remote Similarity NPD9545 Approved
0.6593 Remote Similarity NPD6647 Phase 2
0.6593 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6593 Remote Similarity NPD1930 Approved
0.6593 Remote Similarity NPD1929 Approved
0.6592 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6588 Remote Similarity NPD6232 Discontinued
0.6581 Remote Similarity NPD2567 Approved
0.6581 Remote Similarity NPD2569 Approved
0.6575 Remote Similarity NPD3023 Approved
0.6575 Remote Similarity NPD3026 Approved
0.6571 Remote Similarity NPD7240 Approved
0.6571 Remote Similarity NPD7685 Pre-registration
0.6566 Remote Similarity NPD8455 Phase 2
0.6554 Remote Similarity NPD5327 Phase 3
0.655 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6549 Remote Similarity NPD4766 Approved
0.6548 Remote Similarity NPD3749 Approved
0.6544 Remote Similarity NPD5909 Discontinued
0.6538 Remote Similarity NPD7305 Phase 1
0.6536 Remote Similarity NPD7714 Approved
0.6536 Remote Similarity NPD7715 Approved
0.6533 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6533 Remote Similarity NPD6085 Phase 2
0.6532 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6531 Remote Similarity NPD1281 Approved
0.6529 Remote Similarity NPD6959 Discontinued
0.6527 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6527 Remote Similarity NPD5402 Approved
0.6522 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6519 Remote Similarity NPD970 Clinical (unspecified phase)
0.6517 Remote Similarity NPD6784 Approved
0.6517 Remote Similarity NPD6785 Approved
0.6515 Remote Similarity NPD1989 Approved
0.6507 Remote Similarity NPD17 Approved
0.6507 Remote Similarity NPD3019 Approved
0.6506 Remote Similarity NPD6801 Discontinued
0.6503 Remote Similarity NPD920 Approved
0.6503 Remote Similarity NPD5403 Approved
0.65 Remote Similarity NPD6190 Approved
0.6497 Remote Similarity NPD2935 Discontinued
0.6494 Remote Similarity NPD4307 Phase 2
0.6493 Remote Similarity NPD2066 Phase 3
0.6491 Remote Similarity NPD7229 Phase 3
0.6489 Remote Similarity NPD1202 Approved
0.6486 Remote Similarity NPD6637 Approved
0.6485 Remote Similarity NPD4380 Phase 2
0.6485 Remote Similarity NPD7028 Phase 2
0.6483 Remote Similarity NPD7009 Phase 2
0.6481 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6481 Remote Similarity NPD5401 Approved
0.6481 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6474 Remote Similarity NPD7097 Phase 1
0.6471 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6471 Remote Similarity NPD2313 Discontinued
0.6467 Remote Similarity NPD1470 Approved
0.6456 Remote Similarity NPD1471 Phase 3
0.6456 Remote Similarity NPD5762 Approved
0.6456 Remote Similarity NPD5763 Approved
0.6452 Remote Similarity NPD6355 Discontinued
0.6452 Remote Similarity NPD230 Phase 1
0.6449 Remote Similarity NPD6685 Approved
0.6438 Remote Similarity NPD5691 Approved
0.6437 Remote Similarity NPD7177 Discontinued
0.6434 Remote Similarity NPD690 Clinical (unspecified phase)
0.6424 Remote Similarity NPD2798 Approved
0.642 Remote Similarity NPD6799 Approved
0.642 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6405 Remote Similarity NPD6039 Approved
0.6402 Remote Similarity NPD8320 Phase 1
0.6402 Remote Similarity NPD8319 Approved
0.64 Remote Similarity NPD2198 Approved
0.64 Remote Similarity NPD2199 Approved
0.64 Remote Similarity NPD1283 Approved
0.6398 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6395 Remote Similarity NPD2932 Approved
0.6392 Remote Similarity NPD2531 Phase 2
0.6392 Remote Similarity NPD6100 Approved
0.6392 Remote Similarity NPD6099 Approved
0.6392 Remote Similarity NPD1551 Phase 2
0.6384 Remote Similarity NPD6559 Discontinued
0.6383 Remote Similarity NPD4141 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data